-+ 0.00%
-+ 0.00%
-+ 0.00%

N2OFF Highlights Study Authored By MitoCareX Bio Co-Founder Ciro Leonardo Pierri On Mitochondrial Carriers in Spaceflight Stress Conditions

Benzinga·01/15/2026 13:35:54
Listen to the news

N2OFF, Inc. (NASDAQ:NITO) ("N2OFF" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, today highlighted a newly published peer-reviewed study co-authored by Prof. Ciro Leonardo Pierri, co-founder of MitoCareX Bio Ltd. ("MitoCareX Bio"), N2OFF's wholly-owned subsidiary. The article, appearing in the Journal of Translational Medicine, investigates SLC25A mitochondrial carriers as potential biomarkers and therapeutic targets for dysfunctions induced by spaceflight conditions, including microgravity and cosmic radiation.